Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of ODYSight in the Management of patientS With imparairEd Visual acuitY (ODYSSEY).

NCT06076785 is registered in ClinicalTrials.gov with Tilak Healthcare as lead sponsor.

NCT NCT06076785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06076785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of ODYSight in the Management of patientS With imparairEd Visual acuitY (ODYSSEY).
Lead sponsor
Tilak Healthcare
Phase
Observational
Overall status
Unknown status
Start date
January 27, 2023
Completion date
January 31, 2024
Enrollment
300 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

impaired visual acuity